difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron

Difluoro(5-{2-[(5-octyl‑1H‑pyrrol‑2‑yl‑kappaN)methylidene]‑2H‑pyrrol‑5‑yl‑kappaN}pentanoato)boron is a synthetic small molecule with the molecular formula C22H31BF2N2O2 and a molecular weight of approximately 404.3 g/mol[1][3][4]. It is classified as an experimental compound and has not been approved for any therapeutic use[2]. Structurally related to boron-dipyrromethene (BODIPY) derivatives, it features a difluoroboron core chelated by two pyrrole rings substituted with an octyl group and a pentanoic acid side chain[1][3]. According to computational drug design literature, this compound has been studied as a ligand for peroxisome proliferator–activated receptor alpha (PPARα), suggesting its mechanism of action may involve PPARα activation or modulation[8]. However, there are no clinical trials or approved indications for this molecule.

Other names

difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron12-(4-carboxybutyl)-2,2-difluoro-4-octyl-1,3-diaza-2-boratricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaen